• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    MediWound Ltd. - Ordinary Shares (NQ:MDWD)

    14.21 +0.00 (+0.04%)
    Streaming Delayed Price Updated: 11:18 AM EDT, Jun 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 34,680
    Open 14.20
    Bid (Size) 14.15 (100)
    Ask (Size) 14.24 (100)
    Prev. Close 14.21
    Today's Range 14.13 - 14.36
    52wk Range 13.54 - 21.99
    Shares Outstanding 27,272,818
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    MediWound (MDWD) Q1 2026 Earnings Transcript ↗
    MediWound (MDWD) Q1 2026 Earnings Transcript 
    Via The Motley Fool
    News headline image
    MediWound Q1 Earnings Call Highlights ↗
    MediWound (NASDAQ:MDWD) reported a wider first-quarter loss and lower revenue compared with the prior-year period, while management reaffirmed its 2026 revenue outlook and said it continued to advance... 
    Via MarketBeat
    Topics Earnings

    Performance

    YTD
    -22.8%
    -22.8%
    1 Month
    -13.6%
    -13.6%
    3 Month
    -18.7%
    -18.7%
    6 Month
    -23.2%
    -23.2%
    1 Year
    -33.8%
    -33.8%

    More News

    Read More
    MediWound Ltd. (NASDAQ:MDWD) Q1 2026: Revenue Miss but Narrower Loss, Full-Year Outlook Intact ↗
    Via Chartmill
    News headline image
    MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound Ltd. (NASDAQ:MDWD) Reports Q4 2025 Revenue Miss Despite Pipeline Progress ↗
    Via Chartmill
    News headline image
    MediWound to Report First Quarter 2026 Financial Results
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound Files Annual Report on Form 20-F
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound (MDWD) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    MediWound Reports Fourth Quarter and Full Year 2025 Financial Results
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound to Report Fourth Quarter and Full Year 2025 Financial Results
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound to Present at Upcoming Investor Conferences
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound Ltd (NASDAQ:MDWD) Reports Q3 2025 Earnings: Revenue Misses, EPS Beats Estimates ↗
    Via Chartmill
    News headline image
    MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    Examining the Future: MediWound's Earnings Outlook ↗
    Via Benzinga
    News headline image
    MediWound to Report Third Quarter 2025 Financial Results
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 20, 2025 ↗
    Via Benzinga
    News headline image
    MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
    From MediWound Ltd.
    Via GlobeNewswire

    Frequently Asked Questions

    Is MediWound Ltd. - Ordinary Shares publicly traded?
    Yes, MediWound Ltd. - Ordinary Shares is publicly traded.
    What exchange does MediWound Ltd. - Ordinary Shares trade on?
    MediWound Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for MediWound Ltd. - Ordinary Shares?
    The ticker symbol for MediWound Ltd. - Ordinary Shares is MDWD on the Nasdaq Stock Market
    What is the current price of MediWound Ltd. - Ordinary Shares?
    The current price of MediWound Ltd. - Ordinary Shares is 14.21
    When was MediWound Ltd. - Ordinary Shares last traded?
    The last trade of MediWound Ltd. - Ordinary Shares was at 06/09/26 11:18 AM ET
    What is the market capitalization of MediWound Ltd. - Ordinary Shares?
    The market capitalization of MediWound Ltd. - Ordinary Shares is 387.68M
    How many shares of MediWound Ltd. - Ordinary Shares are outstanding?
    MediWound Ltd. - Ordinary Shares has 388M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.